{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:06:27Z","timestamp":1793333187754,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.parkreldis.2022.04.015","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T20:23:03Z","timestamp":1650918183000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["PET-based classification of corticobasal syndrome"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3023-3836","authenticated-orcid":false,"given":"Yoshikazu","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7139-7178","authenticated-orcid":false,"given":"Hitoshi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shinotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3473-2317","authenticated-orcid":false,"given":"Shigeki","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4551-1491","authenticated-orcid":false,"given":"Kenji","family":"Tagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwamu","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0884-4924","authenticated-orcid":false,"given":"Keisuke","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Takado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-9483","authenticated-orcid":false,"given":"Yasuyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ichise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhiko","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Suhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.parkreldis.2022.04.015_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1440-1789.2003.00543.x","article-title":"Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration","volume":"24","author":"Wakabayashi","year":"2004","journal-title":"Neuropathology"},{"issue":"11","key":"10.1016\/j.parkreldis.2022.04.015_bib2","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.22558","article-title":"Is the pathology of corticobasal syndrome predictable in life?","volume":"24","author":"Shelley","year":"2009","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.04.015_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/s1980-5764-2016dn1004003","article-title":"Corticobasal syndrome: a diagnostic conundrum","volume":"10","author":"Parmera","year":"2016","journal-title":"Dement Neuropsychol"},{"issue":"18","key":"10.1016\/j.parkreldis.2022.04.015_bib4","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/hbm.24782","article-title":"Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment","volume":"40","author":"Chandra","year":"2019","journal-title":"Hum. Brain Mapp."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.04.015_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020110","article-title":"Tauvid\u2122: the first FDA-approved PET tracer for imaging tau pathology in Alzheimer's disease","volume":"14","author":"Jie","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.parkreldis.2022.04.015_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"8","key":"10.1016\/j.parkreldis.2022.04.015_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/WNL.0000000000004264","article-title":"In vivo retention of (18)F-AV-1451 in corticobasal syndrome","volume":"89","author":"Smith","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2022.04.015_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ana.25060","article-title":"(18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study","volume":"82","author":"Schonhaut","year":"2017","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.04.015_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2022.04.015_bib10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00401-016-1618-1","article-title":"[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration","volume":"132","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"22","key":"10.1016\/j.parkreldis.2022.04.015_bib11","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1212\/WNL.0000000000003375","article-title":"In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET","volume":"87","author":"Kikuchi","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2022.04.015_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"issue":"6","key":"10.1016\/j.parkreldis.2022.04.015_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.parkreldis.2022.04.015_bib14","first-page":"764","article-title":"Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies","volume":"140","author":"Ono","year":"2017","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.parkreldis.2022.04.015_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/jnnp-2018-317970","article-title":"Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's disease","volume":"89","author":"Kitamura","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"5","key":"10.1016\/j.parkreldis.2022.04.015_bib16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/mds.27643","article-title":"In vivo binding of a tau imaging probe, [(11) C]PBB3, in patients with progressive supranuclear palsy","volume":"34","author":"Endo","year":"2019","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.04.015_bib17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mds.27623","article-title":"Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features","volume":"34","author":"Ikeda","year":"2019","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.04.015_bib18","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1212\/WNL.0000000000006736","article-title":"Tau imaging detects distinctive distribution of tau pathology in ALS\/PDC on the Kii Peninsula","volume":"92","author":"Shinotoh","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2022.04.015_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/neup.12638","article-title":"Corticobasal degeneration with deep white matter lesion diagnosed by brain biopsy","volume":"40","author":"Arakawa","year":"2020","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/j.parkreldis.2022.04.015_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","article-title":"High-contrast in vivo imaging of tau pathologies in Alzheimer's and non-Alzheimer\u2019s disease tauopathies","volume":"109","author":"Tagai","year":"2021","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.parkreldis.2022.04.015_bib21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.04.015_bib22","first-page":"11","volume":"vol. 6","author":"Shimada","year":"2017"},{"issue":"1","key":"10.1016\/j.parkreldis.2022.04.015_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuroimage.2008.08.045","article-title":"Issues with threshold masking in voxel-based morphometry of atrophied brains","volume":"44","author":"Ridgway","year":"2009","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.parkreldis.2022.04.015_bib24","doi-asserted-by":"crossref","first-page":"e1121","DOI":"10.1212\/WNL.0000000000007038","article-title":"FDG-PET patterns associated with underlying pathology in corticobasal syndrome","volume":"92","author":"Pardini","year":"2019","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2022.04.015_bib25","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.0000000000004364","article-title":"(18)F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome","volume":"89","author":"Cho","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2022.04.015_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13550-016-0182-y","article-title":"A new method to quantify tau pathologies with (11)C-PBB3 PET using reference tissue voxels extracted from brain cortical gray matter","volume":"6","author":"Kimura","year":"2016","journal-title":"EJNMMI Res."},{"issue":"6","key":"10.1016\/j.parkreldis.2022.04.015_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2967\/jnumed.117.200006","article-title":"Flortaucipir F 18 quantitation using parametric estimation of reference signal intensity","volume":"59","author":"Southekal","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.04.015_bib28","doi-asserted-by":"crossref","first-page":"fcab190","DOI":"10.1093\/braincomms\/fcab190","article-title":"Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies","volume":"3","author":"Tezuka","year":"2021","journal-title":"Brain Communications"},{"key":"10.1016\/j.parkreldis.2022.04.015_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X211018904","article-title":"Binding characteristics of [(18)F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET","author":"Song","year":"2021","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.04.015_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/WCO.0000000000000836","article-title":"Immunotherapy in progressive supranuclear palsy","volume":"33","author":"Vaswani","year":"2020","journal-title":"Curr. Opin. Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022001110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022001110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:25:26Z","timestamp":1761179126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802022001110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"alternative-id":["S1353802022001110"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.04.015","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET-based classification of corticobasal syndrome","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}